Tag: Bone formation

In clinical trials, Evenity (romosozumab) has been shown to produce rapid and substantial gains in bone mineral density (BMD), with some studies reporting increases over 15% in the lumbar spine after just 12 months of treatment. This potent, bone-building effect is at the core of understanding how much does evenity increase bone density for patients with severe osteoporosis.

Movymia, a biosimilar medicine approved in the European Union, contains the active substance teriparatide. Unlike many other osteoporosis drugs that prevent bone breakdown, this medication works by actively stimulating new bone formation. Understanding **how does Movymia work** is essential to appreciating its unique and potent approach to managing severe osteoporosis.